2023 Breeder Cultivar Trial at Gardens by the Bay:

"Singapore’s first event of its kind in Southeast Asia"

On Wednesday, November 22, the 2023 Breeder Cultivar Trial at Gardens by the Bay in Singapore will take place. "It is Singapore's first event of its kind in Southeast Asia," the organization says.

This year's program event is tailored to provide valuable insights to growers and landscapers, equipping them with knowledge about the latest flowering plant varieties that thrive in both temperate climates and sunny tropical climates. "Discover the secrets to success for greenhouses and landscapes as Gardens by the Bay shares the highlights of our 2023 breeder cultivar trials. Dive deep into the art and science of plant propagation through informative presentations."

Renowned industry experts from leading international plant breeders such as PanAmerican Seed, Suntory Flowers, Syngenta Flowers, and Takii Seed will showcase their top-performing genetics featured in the trial. "Additionally, gain valuable insights into peat and wood fiber substrates used in these trials, presented by industry pioneers Klasmann-Deilmann and Pindstrup."

It will take place on Wednesday, November 22, from 1.00 pm to 6.00 pm. The venue is the research glasshouse at Gardens by the Bay. "The location provides an ideal setting to immerse yourself in the world of plant innovation."

Registration is free and open to all members of the industry.

Program Highlights

  • 1.00 pm: On-site registration opens for participants
  • 2.00 pm: Introduction to the 2023 trials and breeder presentations of top-performing cultivars
  • 3.10 pm: Break
  • 3.30 pm: Presentation: Art and Science of Plant Propagation
  • 4.00 pm: Presentation: Growing in Peat and Wood Fibre Substrates
  • 4.30 pm: Viewing of cultivars and refreshments
  • 6.00 pm: End of event

Click here to register.

For more information:
Gardens By the Bay

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.